MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Infectious Disease_Hepatitis
Sequoia Pharmaceuticals
Parents
*Architects: Infectious Disease _ HIV/AIDS & STDs
*Architects: Infectious Disease _ Virology_Antiviral, Antivirus
*Architects: Infectious Disease_Hepatitis
*Industry: Gaithersburg, Maryland
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
*Portfolio Companies: Aberdare
*Portfolio Companies: Healthcare Ventures
*Portfolio Companies: Sofinnova
Venture Capital: Series C
Wellcome Trust
Children
Cindy Collins, President & CEO, Sequoia Pharmaceuticals
Discovers and develops new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis
Focus on the growing problem of drug-resistant infectious diseases
Founded 2002
Gaithersburg, Maryland
Press Release: Sequoia Pharmaceuticals Raises $35M In Series C Financing (2007)
The company’s lead program is focused on the development of protease inhibitors
The Wellcome Trust led the round of financing and was joined by other existing investors including Healthcare Venture, Sofinnova Partners, and Aberdare Ventures as well as new investor, MedImmune Ventures, Inc. Read more: Press Release: Sequoia Pharmaceuti